Final Oocyte Maturation Via Administration of GnRH Agonists Followed By Luteal Support With hCG

PHASE4CompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

July 31, 2017

Study Completion Date

August 31, 2017

Conditions
Infertility
Interventions
DRUG

TRIPTORELIN ACETATE, hCG

In the study group women will receive GnRH agonist (decapeptyl 0.2 mg) for oocyte maturation, followed by ovum pick-up which will be performed 35 hours later. Embryo transfer will be performed 48-72 hours after ovum pick-up. Luteal support will include HCG 1500 IU.

Trial Locations (1)

18101

Hemek medical centre, Afula

All Listed Sponsors
lead

HaEmek Medical Center, Israel

OTHER

NCT01638026 - Final Oocyte Maturation Via Administration of GnRH Agonists Followed By Luteal Support With hCG | Biotech Hunter | Biotech Hunter